Antiplatelet therapy (AT) may serve to reduce the effects of aneurysmal subarachnoid
hemorrhage (aSAH)-induced pro-coagulant state in the cerebral circulation. Several studies …

Antiplatelet treatment (APT) has been reported to be used in some patients with aneurysmal
subarachnoid hemorrhage (aSAH) after endovascular treatment, but there is controversy …

Background: Rescue treatment for delayed cerebral ischemia (DCI) after subarachnoid
hemorrhage can include induced hypertension (iHTN) and, in refractory cases …

Abstract The 2023 International Subarachnoid Hemorrhage Conference identified a need to
provide an up-to-date review on prevention methods for delayed cerebral ischemia (DCI) …

Background The efficacy of antiplatelet therapy (APT) after aneurysmal subarachnoid
hemorrhage (aSAH) remains unclear. We performed a systematic review and meta-analysis …

Background Cerebral vasospasm is a leading source of delayed morbidity and mortality
after aneurysmal subarachnoid hemorrhage (aSAH). Angioplasty may improve vasospasm …

Mortality after aneurysmal subarachnoid hemorrhage (aSAH) is augmented by rebleeding
and delayed cerebral ischemia (DCI). A range of assays evaluating the dynamic process of …

Background Although delayed cerebral ischemia (DCI) commonly complicates recovery in
survivors of aneurysmal subarachnoid hemorrhage (aSAH), its pathophysiology is …

Here, we describe a series of 7 patients who presented with acute paraparesis due to
anterior communicating artery aneurysm rupture. This study aimed to assess the clinical and …

Purpose Aspirin has beneficial effects on coiling, even in acute subarachnoid hemorrhage,
but there is also a perceived risk of increased bleeding and, importantly, a concern …